The future of early cancer detection.

Journal: Nature medicine
Published Date:

Abstract

A proactive approach to detecting cancer at an early stage can make treatments more effective, with fewer side effects and improved long-term survival. However, as detection methods become increasingly sensitive, it can be difficult to distinguish inconsequential changes from lesions that will lead to life-threatening cancer. Progress relies on a detailed understanding of individualized risk, clear delineation of cancer development stages, a range of testing methods with optimal performance characteristics, and robust evaluation of the implications for individuals and society. In the future, advances in sensors, contrast agents, molecular methods, and artificial intelligence will help detect cancer-specific signals in real time. To reduce the burden of cancer on society, risk-based detection and prevention needs to be cost effective and widely accessible.

Authors

  • Rebecca C Fitzgerald
    MRC Cancer Unit, University of Cambridge, Cambridge, United Kingdom.
  • Antonis C Antoniou
    Centre for Cancer Genetic Epidemiology, Department of Public Health & Primary Care, University of Cambridge, Cambridge, UK.
  • Ljiljana Fruk
    Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
  • Nitzan Rosenfeld
    Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.